DCM Shriram Board Recommends ₹4 Final Dividend, Approves HSCL Capex & AGM on 18 Aug 26
DCM Shriram's board approved audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹4 per share, bringing the total dividend for FY26 to ₹11.20 per share, subject to shareholder approval. The 37th AGM is scheduled for August 18, 2026. Additionally, a ₹101 crore capex plan for HSCL was approved, with DCM Shriram providing up to ₹100 crore in financial assistance.
The dividend announcement and capex plan can have a moderate positive impact on investor sentiment and company growth.
The announcement includes positive elements such as dividend recommendation, approval of financial results, and investment in subsidiary's expansion.
The Board of Directors of DCM Shriram Limited, in its meeting on 13th May 2026, approved the audited financial results (both standalone and consolidated) for the quarter and financial year ended 31st March 2026. They recommended a final dividend of 200%, i.e., ₹4 per equity share of face value ₹2 each, subject to shareholder approval at the 37th Annual General Meeting (AGM). If approved, the total dividend for FY26 would be ₹11.20 per share, including two interim dividends of ₹3.60 per share each declared earlier. The final dividend will be paid within 30 days from the AGM date. 37th AGM of the shareholders of the Company will be convened on Tuesday, 18th August 2026. The board also considered and approved, subject to shareholder approval, the cancellation of 39,00,000 forfeited equity shares of the Company. These shares, originally 7,80,000 equity shares of ₹10 each forfeited in January 2005, were converted following a stock split in October 2005 and the aggregate amount paid-up on such forfeited shares is ₹15.60 lakhs. Further, the board approved a capital expenditure plan of ₹101 crore for Hindusthan Specialty Chemicals Ltd (HSCL) to increase Formulated Resins (FR) capacity by 36K TPA, reaching a total of 50K TPA. DCM Shriram will provide financial assistance of up to ₹100 crore to HSCL through a mix of equity and debt. The Board meeting commenced at 11:00 A.M. and concluded at 5:15 P.M. on 13th May 2026.
What to do with a filing like this
DCM Shriram Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by DCM Shriram Limited. Read the original for the full detail.